Sign In
Buy ENLV
$0.611
-0.0122 (-1.96%)
At Close: Jun 23, 2026
Enlivex Therapeutics Ltd. Announces Withdrawal of Proposed Offering of Ordinary Shares
12:30pm, Thursday, 21'st Nov 2019
Enlivex Therapeutics Ltd. (“Enlivex” or the “Company”) (ENLV) today announced that it has withdrawn its previously announced proposed underwritten public offering of ordinary shares due to mar
Enlivex Therapeutics Ltd. Announces Proposed Offering of Ordinary Shares
09:14pm, Wednesday, 20'th Nov 2019
The Company intends to grant the underwriter an option for a period of 45 days to purchase up to an additional 15 percent of the number of Shares to be issued and sold in the public offering solely to
Enlivex announced on November 4, 2019 positive interim safety and efficacy data from an ongoing trial of off-the-shelf universal Allocetra in patients with severe sepsis. The interim analysis compari
Enlivex Therapeutics To Present At The 10th Annual Jefferies 2019 London Healthcare Conference
12:30pm, Tuesday, 12'th Nov 2019
Nes-Ziona, Israel, Nov. 12, 2019 -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that company management will make a.
Company News For Nov 5, 2019
01:42pm, Tuesday, 05'th Nov 2019
Companies In The News Are: WMGI, ENLV, CRNT, UAA
